NewLimit
Backed by
NewLimit is a biotechnology company working to radically extend human healthspan. They are developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells.
Scientist, Lipid Nano Particle Delivery
South San Francisco, CA · Posted on Sep 8, 2025
Scientist/Senior Scientist, Immunology
South San Francisco, CA · Posted on Aug 27, 2025
Senior/Research Associate, Metabolism
South San Francisco · Posted on Aug 27, 2025
Senior/Research Associate, Functional Genomics
South San Francisco, CA · Posted on Jun 23, 2025
Group Leader, Immunology
South San Francisco, CA · Posted on Apr 21, 2025
Scientist/Senior Scientist, Functional Genomics
South San Francisco, CA · Posted on Apr 21, 2025
Explore similar companies to NewLimit
Chai Discovery
Engineering better molecules using artificial intelligence.
CuspAI
Frontier AI for breakthrough materials.
Enveda
Advancing nature-inspired drugs.
Kingdom Supercultures
Natural functional ingredients that actually work.
Cradle
Designing better proteins.
Astromech
Navigating the code of life.
Invert
Modern software for bioprocess data.
Sway
Seaweed as replacement for plastic.
Convoke
AI-native OS for drug development.